Green, Ari J <br/><br/>
Clemastine fumarate as a remyelinating therapy for multiple sclerosis (ReBUILD): a randomised, controlled, double-blind, crossover trial.  [electronic resource] 

 -  Lancet (London, England)  Dec 2017 
 - 2481-2489 p.  digital 
<br/><br/> Publication Type: Journal Article; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>1474-547X 
<br/><br/><label>Standard No.: </label>10.1016/S0140-6736(17)32346-2  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Clemastine--therapeutic use<br/>Cross-Over Studies<br/>Double-Blind Method<br/>Evoked Potentials, Visual--drug effects<br/>Female<br/>Humans<br/>Male<br/>Multiple Sclerosis--drug therapy<br/>Remyelination--drug effects<br/>Tomography, Optical Coherence<br/>Treatment Outcome